The world's first international cryogenic biomedical research system was officially launched - Yinfeng Cryo opens a new era of international cryogenic medicine exploration
Release time:
2022-12-17
On December 16, 2022, the "world's first international low-temperature biomedical research system" was officially launched. Once the news was released, it attracted the attention of many parties, including China Daily, Jinan Daily, Qilu Evening News, Qilu One Point Client Headline Channel, Today's Toutiao, Tencent News, NetEase News, Baidu News, Sina News and other mainstream media rushed to report on it.
Among them, "China Daily" is an important window for China to understand the world and the world to understand China. It is the first choice of Chinese English media for professionals at home and abroad. It is also a Chinese newspaper that has entered the international mainstream society and has the highest reprint rate by foreign media.
The development of medicine is related to the life and health of all mankind. In the field of cutting-edge medical research, cryogenic medicine has attracted much attention due to its fruitful clinical application results and strong development momentum. In December 2022, the world's first international cryogenic biomedical research system was officially launched. The system was organized and established by the Yinfeng Cryomedicine Research Center as the system's scientific research results sharing platform and academic exchange guidance platform - Yinfeng Cryomedicine Second The expert committee was simultaneously announced to be established.
The international cryogenic biomedical research system is organized and initiated by the Yinfeng Cryomedical Research Center and is jointly established by domestic and international cryogenic biomedical research scholars and scientific research institutions. The system includes 11 major scientific research projects and 30 subdivided projects, including cryopreservation principles, cryopreservation technology, cryopreservation methods, cryopreservation materials, cryopreservation applications, and cryogenic medicine, covering the current key areas and development of global cryogenic medicine research. direction, and jointly promote the development of cryogenic medicine in a systematic and collaborative manner.
Guided by the system and cultivated by the platform, the second Yinfeng Cryomedicine Expert Committee aims to build an information sharing platform for the international cryogenic biomedical research system. The expert committee is composed of 22 international and domestic experts and scholars from cryogenic biomedicine, cryopreservation of human tissues and organs, clinical scientific research, biomaterials, medical ethics, law, engineering, journalism and communication and other related fields. Starting from 2023, the second expert committee of Yinfeng Cryomedicine will organize the preparation of the "International Cryobiomedicine Research System White Paper" to comprehensively elaborate on the development background, system composition, current results and future research and development directions of cryogenic biomedicine, and provide a basis for international cryogenic medicine. Contribute to China’s development.
Hypothermia medicine is an emerging interdisciplinary discipline that has gradually formed in recent decades. It integrates life sciences, modern medicine and cryogenic technology, hoping to cure human diseases and protect human health through cryogenic technology. After continuous efforts, cryogenic medicine has now been able to achieve the cryopreservation and recovery of human germ cells, stem cells, umbilical cord blood, ovarian tissue, testicular tissue, embryos and other human cells, tissues and organs, and has been widely used in clinical practice, helping thousands of people The patient regains his health. As a result, cryogenic medicine has become one of the rapidly developing, anticipated and remarkable disciplines in the field of life sciences.
The rapid development of cryogenic medicine relies on a strong scientific research team. The Yinfeng Cryomedicine Research Center, which promotes the establishment of an international cryogenic biomedical research system, is affiliated with Yinfeng Biological Group. Currently, Yinfeng Biological Group operates 14 national, provincial and municipal stem cell banks and genetic resource banks, with more than 800,000 cryopreserved stem cells and a total cell storage capacity of more than 5 million. And has mastered the cryopreservation and recovery technology of various human tissues and organs, including ovarian tissue, skin, severed fingers (toes), valves, blood vessels, etc.
The international cryogenic biomedical research system organized and led by the Yinfeng cryogenic medicine team will build an academic exchange and achievement sharing platform for global cryogenic biomedical research teams, integrate international and domestic scientific research academic forces in multiple fields, and build a systematic cryogenic medical research system. Jointly promote the development of cryogenic medicine research and let global cryogenic medicine researchers gather into a powerful force of organic synergy.
People's health is an important symbol of national prosperity and national strength. As the 20th National Congress of the Communist Party of China emphasized: adhere to science and technology as the primary productive force, talent as the primary resource, and innovation as the primary driving force, adhere to the innovation-driven development strategy, promote the construction of a healthy China, and put the protection of people's health in a strategic position of priority development. This further points out the direction for China's cryogenic biomedical research in the new era - as a forward-looking field of human medical research, cryogenic medicine must firmly face the world's technological frontiers, persist in facing people's lives and health, and accelerate the realization of high-level self-reliance and self-reliance.
The international low-temperature biomedical research system has the vision of benefiting the health of all mankind. It will become a vigorous force for scientific and technological innovation in the medical and health field, actively shoulder the historical mission of promoting the development of human health, and work hard to create a glorious era of cryogenic medicine!
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
